Search research articles
Contact Us
Filters
Showing results (161-170 of 220) with videos related to
Page
of 22
Sort By:
Cancers
|
May 25, 2024
The [<sup>18</sup>F]F-FDG PET/CT Radiomics Classifier of Histologic Subtypes and Anatomical Disease Origins across Various Malignancies: A Proof-of-Principle Study
Ricarda Hinzpeter, Seyed Ali Mirshahvalad, Vanessa Murad, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 19, 2013
Protocol requirements and diagnostic value of PET/MR imaging for liver metastasis detection
Caecilia S Reiner, Paul Stolzmann, Lars Husmann, et al.
Academic Radiology
|
July 13, 2024
Predictive [<sup>18</sup>F]-FDG PET/CT-Based Radiogenomics Modelling of Driver Gene Mutations in Non-small Cell Lung Cancer
Ricarda Hinzpeter, Roshini Kulanthaivelu, Andres Kohan, et al.
Clinical Nuclear Medicine
|
May 22, 2024
Comparison of Multiparametric MRI and the Combination of PSMA Plus MRI for the Intraprostatic Diagnosis of Prostate Cancer: A Systematic Review and Meta-Analysis
Giovanni Brondani Torri, Pedro Antune Pereira, Camila Piovesan Wiethan, et al.
Radiology
|
August 8, 2014
Whole-body nonenhanced PET/MR versus PET/CT in the staging and restaging of cancers: preliminary observations
Martin W Huellner, Philippe Appenzeller, Félix P Kuhn, et al.
Acta Oncologica (Stockholm, Sweden)
|
July 21, 2020
Prognostic value of O-(2-[<sup>18</sup>F]-fluoroethyl)-L-tyrosine PET in relapsing oligodendroglioma
Florian Schneider, Fabian Wolpert, Paul Stolzmann, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 11, 2015
Tumor stage, tumor site and HPV dependent correlation of perfusion CT parameters and [18F]-FDG uptake in head and neck squamous cell carcinoma
Marta Nesteruk, Stephanie Lang, Patrick Veit-Haibach, et al.
Clinical Nuclear Medicine
|
February 3, 2026
The PRIMARY Scoring System on PSMA PET for Clinically Significant Prostate Cancer Detection: A Systematic Review and Meta-Analysis
Felipe A Mourato, Luiza G Schmitt, Miriana Mariussi, et al.
European Journal of Hybrid Imaging
|
December 16, 2021
Combined simultaneous FDG-PET/MRI with T1 and T2 mapping as an imaging biomarker for the diagnosis and prognosis of suspected cardiac sarcoidosis
Edward Cheung, Sarah Ahmad, Matthew Aitken, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 9, 2018
Feasibility of <sup>18</sup>F-FDG Dose Reductions in Breast Cancer PET/MRI
Bert-Ram Sah, Soleen Ghafoor, Irene A Burger, et al.
Page
of 22
Search research articles
Search
Showing results (161-170 of 220) with videos related to
Sort By:
Page
of 22
Cancers
|
May 25, 2024
The [<sup>18</sup>F]F-FDG PET/CT Radiomics Classifier of Histologic Subtypes and Anatomical Disease Origins across Various Malignancies: A Proof-of-Principle Study
Ricarda Hinzpeter, Seyed Ali Mirshahvalad, Vanessa Murad, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 19, 2013
Protocol requirements and diagnostic value of PET/MR imaging for liver metastasis detection
Caecilia S Reiner, Paul Stolzmann, Lars Husmann, et al.
Academic Radiology
|
July 13, 2024
Predictive [<sup>18</sup>F]-FDG PET/CT-Based Radiogenomics Modelling of Driver Gene Mutations in Non-small Cell Lung Cancer
Ricarda Hinzpeter, Roshini Kulanthaivelu, Andres Kohan, et al.
Clinical Nuclear Medicine
|
May 22, 2024
Comparison of Multiparametric MRI and the Combination of PSMA Plus MRI for the Intraprostatic Diagnosis of Prostate Cancer: A Systematic Review and Meta-Analysis
Giovanni Brondani Torri, Pedro Antune Pereira, Camila Piovesan Wiethan, et al.
Radiology
|
August 8, 2014
Whole-body nonenhanced PET/MR versus PET/CT in the staging and restaging of cancers: preliminary observations
Martin W Huellner, Philippe Appenzeller, Félix P Kuhn, et al.
Acta Oncologica (Stockholm, Sweden)
|
July 21, 2020
Prognostic value of O-(2-[<sup>18</sup>F]-fluoroethyl)-L-tyrosine PET in relapsing oligodendroglioma
Florian Schneider, Fabian Wolpert, Paul Stolzmann, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 11, 2015
Tumor stage, tumor site and HPV dependent correlation of perfusion CT parameters and [18F]-FDG uptake in head and neck squamous cell carcinoma
Marta Nesteruk, Stephanie Lang, Patrick Veit-Haibach, et al.
Clinical Nuclear Medicine
|
February 3, 2026
The PRIMARY Scoring System on PSMA PET for Clinically Significant Prostate Cancer Detection: A Systematic Review and Meta-Analysis
Felipe A Mourato, Luiza G Schmitt, Miriana Mariussi, et al.
European Journal of Hybrid Imaging
|
December 16, 2021
Combined simultaneous FDG-PET/MRI with T1 and T2 mapping as an imaging biomarker for the diagnosis and prognosis of suspected cardiac sarcoidosis
Edward Cheung, Sarah Ahmad, Matthew Aitken, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 9, 2018
Feasibility of <sup>18</sup>F-FDG Dose Reductions in Breast Cancer PET/MRI
Bert-Ram Sah, Soleen Ghafoor, Irene A Burger, et al.
Page
of 22